Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.28M | 4.86M | 7.84M | 7.07M | 882.65K |
Gross Profit | 1.79M | -13.43M | -744.00K | 1.66M | -539.92K |
EBITDA | -16.92M | -53.23M | -44.62M | -34.07M | -3.05M |
Net Income | -40.99M | -71.40M | -74.34M | -20.52M | -993.85K |
Balance Sheet | |||||
Total Assets | 8.01M | 34.74M | 89.59M | 163.03M | 93.92M |
Cash, Cash Equivalents and Short-Term Investments | 381.00K | 3.56M | 32.87M | 79.76M | 24.95K |
Total Debt | 832.00K | 10.42M | 12.08M | 137.81K | 2.77M |
Total Liabilities | 29.30M | 21.29M | 25.44M | 32.83M | 88.92M |
Stockholders Equity | -21.30M | 13.45M | 64.15M | 130.20M | 5.00M |
Cash Flow | |||||
Free Cash Flow | 1.31M | -36.74M | -46.33M | -41.98M | -3.32M |
Operating Cash Flow | 1.40M | -32.12M | -32.13M | -35.84M | -3.20M |
Investing Cash Flow | 1.21M | -6.23M | -14.52M | -25.56M | 132.93M |
Financing Cash Flow | 850.00K | 9.06M | -40.00K | 141.50M | -130.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
54 Neutral | $490.42M | -3.15 | -160.01% | ― | -82.87% | -59.38% | |
50 Neutral | $47.43M | -15.72 | -24.56% | ― | -46.17% | -54.38% | |
44 Neutral | $9.05M | ― | -771.66% | ― | -98.36% | 56.27% | |
43 Neutral | $8.36M | -0.33 | -107.78% | ― | ― | ― | |
32 Underperform | $5.26M | -0.30 | ― | ― | ― | ― | |
31 Underperform | $5.82M | -0.84 | ― | ― | ― | -75.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
On August 28, 2025, Advent Technologies Holdings entered into a Securities Purchase Agreement with Hudson Global Ventures LLC, resulting in a loan evidenced by a Convertible Promissory Note of $418,000. By September 11, 2025, Advent Technologies repaid the loan in full, terminating the Promissory Note and fulfilling all associated conditions, which may positively impact the company’s financial stability and stakeholder confidence.
The most recent analyst rating on (ADN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Advent Technologies Holdings stock, see the ADN Stock Forecast page.
On August 28, 2025, Advent Technologies Holdings, Inc. entered into a Securities Purchase Agreement with Hudson Global Ventures LLC, resulting in a loan of $418,000 evidenced by a Convertible Promissory Note. The agreement includes a pre-funded warrant for Hudson to purchase 130,000 shares of common stock. The loan will be repaid in eleven monthly installments starting October 1, 2025, with a maturity date of August 1, 2026. The funds will be used for corporate expenses and working capital, and the agreement includes various rights and conditions for Hudson in case of fundamental transactions or defaults.
The most recent analyst rating on (ADN) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Advent Technologies Holdings stock, see the ADN Stock Forecast page.
On October 18, 2024, Advent Technologies Holdings was notified by Nasdaq that it was not in compliance with a listing rule requiring a minimum stockholders’ equity of $2,500,000. Although the company believed it had regained compliance by April 16, 2025, it failed to meet the necessary equity adjustments in its quarterly report filed on August 12, 2025. Consequently, on August 18, 2025, Nasdaq issued a delist determination letter, prompting the company to appeal the decision to prevent its securities from being delisted.
The most recent analyst rating on (ADN) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Advent Technologies Holdings stock, see the ADN Stock Forecast page.